VBI Vaccines Inc Business Finance Contracts & Agreements
46 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Contribution Agreements (2)
- Credit Agreements (6)
- Forbearance Agreements (7)
- Funding Agreements (3)
- Loan Agreements (4)
- Purchase Agreements (1)
- Release Agreements (3)
- Security Agreements (1)
- Stock Agreements (2)
- Subscription Agreements (1)
- Underwriting Agreements (5)
- Waiver Agreements (1)
- Warrant Agreements (7)
- Extension to Forbearance Agreement, dated February 6, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated January 23, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated January 9, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated December 26, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated December 12, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated November 28, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 11, 2024)
- Form of Placement Agent Warrant (Filed With SEC on April 11, 2024)
- Form of Common Warrant (Filed With SEC on April 11, 2024)
- Forbearance Agreement, dated November 13, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on November 14, 2023)
- Third Amendment to Loan and Guaranty Agreement, dated July 5, 2023, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each... (Filed With SEC on August 14, 2023)
- Form of Underwritten Warrant (Filed With SEC on July 7, 2023)
- Underwriting Agreement dated July 6, 2023 between the Company and Raymond James & Associates, Inc. as Representative of the Several Underwriters (Filed With SEC on July 7, 2023)
- Stock Purchase Agreement dated July 5, 2023 between the Company and Brii Biosciences Limited (Filed With SEC on July 5, 2023)
- Amendment to Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition... (Filed With SEC on March 13, 2023)
- Press Release dated September 15, 2022 (Filed With SEC on September 15, 2022)
- Second Amendment to Loan and Guaranty Agreement, dated as of September 14, 2022, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower... (Filed With SEC on September 15, 2022)
- Amendment to the Contribution Agreement, signed March 28, 2022, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as... (Filed With SEC on May 9, 2022)
- Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (Filed With SEC on March 7, 2022)
- Form of Amended and Restated Warrant (Filed With SEC on May 21, 2021)
- First Amendment to Loan and Guaranty Agreement, dated as of May 17, 2021, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative,... (Filed With SEC on May 21, 2021)
- Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (Filed With SEC on May 10, 2021)
- Amendment to the Assignment Agreement, dated February 14, 2013, by and among SciGen Ltd., SciGen (I.L.) Ltd (Filed With SEC on March 2, 2021)
- Assignment Agreement, dated October 16, 2012, by and among FDS Pharma LLP, SciGen Ltd., and SciGen (I.L.) Ltd (Filed With SEC on March 2, 2021)
- Assignment Agreement, dated February 14, 2012, between FDS Pharma LLP and SciGen Ltd (Filed With SEC on March 2, 2021)
- Contribution Agreement, dated September 16, 2020, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as Represented by... (Filed With SEC on November 2, 2020)
- Form of Warrant (Filed With SEC on May 27, 2020)
- Loan and Guaranty Agreement, dated as of May 22, 2020, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each of the... (Filed With SEC on May 27, 2020)
- Form of Warrant Agreement (Filed With SEC on April 27, 2020)
- Underwriting Agreement, dated April 22, 2020, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on April 24, 2020)
- Waiver Agreement, dated February 25, 2020, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on March 5, 2020)
- Underwriting Agreement, dated September 19, 2019, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on September 20, 2019)
- Waiver Agreement, dated February 14, 2019, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on February 25, 2019)
- Stock Purchase Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
- Amendment No. 3 to Amended and Restated Credit Agreement and Guaranty and Amendment to Warrant, dated January 31, 2019, by and among Variation Biotechnologies (US), Inc., the... (Filed With SEC on February 5, 2019)
- Underwriting Agreement, dated December 13, 2018, by and among the Company and BMO Capital Markets Corp., Canaccord Genuity LLC and Oppenheimer & Co., Inc., as representatives of... (Filed With SEC on December 17, 2018)
- Amendment No.2 to Amended and Restated Credit Agreement and Guaranty and Amendment to Warrant, dated July 17, 2018, by and among Variation Biotechnologies (US), Inc., the... (Filed With SEC on July 19, 2018)
- Waiver Agreement, dated February 21, 2018, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on February 26, 2018)
- Form of Warrant, dated October 30, 2017 (Filed With SEC on October 31, 2017)
- Form of Subscription Agreement, between the Company and the investor parties thereto (Filed With SEC on October 27, 2017)
